ESR1 and breast cancer: When looking at expression of LAT2 in tumor tissues, LAT2 expression was associated with improved survival in estrogen receptor positive (ER+) breast cancer (Thakkar et al., 2015; El Ansari et al., 2020) and in lung cancer (Asada et al., 2020).